Answers are grounded in this paper and cite their sources.
Background: People living with HIV (PLWH) may have altered immune responses to COVID-19 vaccination. This study compared the immunogenicity of AZD1222 (COVISHIELD) and BBV152 (COVAXIN) vaccines between PLWH and HIV-negative individuals. Methods: Blood samples were collected from 45 PLWH and 45 HIV-negative controls aged 18–72 years who had received either partial or complete SARS-CoV-2 vaccination (including booster doses). Neutralizing antibody and T-cell-specific immune responses were measured. Results: PLWH exhibited lower neutralizing antibody and T-cell-specific immune responses compared to HIV-negative controls, after controlling for vaccine type, age, and vaccination status. Reduced immune responses were particularly observed in PLWH with low CD4 T-cell counts (<500 cells/µL), high HIV viral loads (>200 copies/mL), recent HIV diagnosis (2–5 years), or on second-line ART. Conclusion: COVID-19 vaccination elicits lower immune responses in certain PLWH subgroups, highlighting the importance of vaccination and monitoring immune responses in this population.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: